The FDA has cleared the Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio test, the first blood test for early Alzheimer's ...

Faithful representation of the market at a low price tag. However, it is more concentrated among the largest emerging markets while possessing a level of political risk absent from developed ...

Despite recent underperformance, this strategy has appeal for the long term. Our research team assigns Neutral ratings to strategies they’re not confident will outperform a relevant index, or ...

Ajay Kela is the president and CEO of Wadhwani Foundation, a nonprofit using technology to accelerate ‘dignified jobs’ growth ...